MYO vs NDAQ · rev $21.8M vs P/E 41, rev $2.53B
Myomo Inc (MYO) versus Nasdaq Inc (NDAQ) — a side-by-side from cached financials, not a winner call.
Myomo Inc (MYO) is a medical devices company listed on AMEX.
Nasdaq Inc (NDAQ) is a financial data & stock exchanges company listed on US.
Latest reported MYO revenue for 2026-06-30 was $21.8M. Net income was -$7.0M. MYO currently screens at market cap $57.6M.
Latest reported NDAQ revenue for 2026-06-30 was $2.53B. Net income was $507.0M. Revenue was up 18.5% from 2026-03-31 to 2026-06-30. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
MYO currently screens at market cap $57.6M. NDAQ currently screens at market cap $51.71B and trailing P/E 40.8.
Not investment advice. Open the MYO and NDAQ stock pages for the full models.
Not investment advice.